Manoranjan S D'Souza

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Multiple Sclerosis

Top Venues

The Annals of pharmacotherapy

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

The European journal of neuroscience

Ohio Northern University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ohio Northern University Sep 01 2013

United States

Associate Professor :: Pharmaceutical and Biomedical Sciences

Publications

Haley Raible, Manoranjan S D'Souza
Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents. The Annals of pharmacotherapy (2023)
Lindsey Peters, Megan Dyer, Emily Schroeder, Manoranjan S D'Souza
Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia. The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 39 (2) (2023)
Amal Alnaif, Isabelle Oiler, Manoranjan S D'Souza
Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis. The Annals of pharmacotherapy (2022)
Boyd R Rorabaugh, Lisanne Sprague, Haval Norman, Sarah L Seeley, Manoranjan S D'Souza
Regulator of G protein signaling 2 differentially regulates nicotine-induced anxiolytic- and antidepressant-like effects in mice. The European journal of neuroscience 48 (5) (2018)